Valneva SE (i.) Is a specialized biotechnology company that focuses on the development and marketing of vaccines against infectious diseases. The commercial portfolio of Valneva comprises three main vaccines: Ixiaro against Japanese encephalitis, dukoral to prevent cholera and Ixchiq, the world’s first approved vaccine against Chikungunya. Among other things, the market -leading position of the group contributed to the fact that the American Ministry of Defense had the vaccine against Japanese encephalitis …
